EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Inflammatory Bowel Disease (IBD)-Associated Colorectal Cancer (CRC): Is cGAS-STING Pathway Targeting the Key to Chemoprevention?

Stavros P Papadakos iD, Chara Georgiadou, Alexandra Argyrou, Elisavet Michailidou, Charalampos Thanos, Stamatina Vogli iD, Spyros I Siakavellas, Spillios Manolakopoulos, Stamatios Theocharis

International Journal of Molecular Sciences · 22.05.2025 · 26 (11) · 4979

DOI: 10.3390/ijms26114979 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 22.05.2025. Verfasst von Stavros P Papadakos und 8 weiteren Autor:innen. Beteiligte Einrichtung: First Department of Pathology, School of Medicine, National and Kapodistrian University of Athens, 11527 Athens, Greece. Hauptthemen laut MEDLINE: Nucleotidyltransferases, Membrane Proteins, Colorectal Neoplasms, Inflammatory Bowel Diseases. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 100 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Inflammatory bowel disease (IBD)-associated colorectal cancer (CRC) remains a significant clinical challenge due to its link with chronic inflammation and the inherent limitations of current prevention and surveillance strategies. The cGAS-STING pathway has emerged as a key player in the immune regulation of inflammation-driven carcinogenesis, demonstrating both protective and pathogenic roles. This review examines the contrasting roles of the cGAS-STING signaling pathway in intestinal inflammation and colitis-associated cancer (CAC), emphasizing its promise as a target for cancer prevention strategies. Evidence suggests that modulating this pathway could preserve epithelial integrity, limit chronic inflammation, and bolster anti-tumor immunity. Despite advancements in therapies like mesalazine and surveillance colonoscopy programs, gaps in efficacy remain, particularly for Crohn’s disease and high-risk populations. Future research should focus on integrating cGAS-STING-targeted approaches with existing modalities to provide personalized and less invasive strategies for CAC prevention. By harnessing this pathway’s therapeutic potential, a paradigm shift in managing IBD-associated CRC may be achieved, addressing the challenges of long-term disease surveillance and prevention.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NucleotidyltransferasesMembrane ProteinsColorectal NeoplasmsInflammatory Bowel DiseasesHumansSignal TransductionAnimalsChemopreventionSTING ProteinCyclic Guanosine Monophosphate-Adenosine Monophosphate Synthase

Stichwörter der Autor:innen

cGAS-STING pathwaychemopreventioncolitis-associated colorectal cancer (CAC)inflammatory bowel disease (IBD)innate immunity

Substanzen

NucleotidyltransferasesMembrane ProteinsSTING1 protein, humanSTING ProteincGAS protein, humanCyclic Guanosine Monophosphate-Adenosine Monophosphate Synthase

Autor:innen und Institutionen

  • First Department of Pathology, School of Medicine, National and Kapodistrian University of Athens, 11527 Athens, Greece.
  • 1st Department of Gastroenterology, Medical School of National and Kapodistrian University of Athens, General Hospital of Athens "Laiko", 11527 Athens, Greece.
  • Department of Physiology, Medical School of National and Kapodistrian University of Athens, 75 Mikras Asias Str, 11527 Athens, Greece.
  • Department of Gastroenterology, General Hospital of Athens "G. Gennimatas", 11527 Athens, Greece.
  • Department of Gastroenterology, Metaxa Cancer Hospital of Piraeus, 18537 Piraeus, Greece.
  • Liver-GI Unit, 2nd Academic Department of Internal Medicine, General Hospital of Athens "Hippocration", National and Kapodistrian University of Athens, 11527 Athens, Greece.

ORCID-Profile: Stavros P Papadakos, Stamatina Vogli

Zitieren

APA

Papadakos, S. P., Georgiadou, C., Argyrou, A., Michailidou, E., Thanos, C., Vogli, S., Siakavellas, S. I., Manolakopoulos, S., & Theocharis, S. (2025). Inflammatory Bowel Disease (IBD)-Associated Colorectal Cancer (CRC): Is cGAS-STING Pathway Targeting the Key to Chemoprevention?. International Journal of Molecular Sciences, 26(11), 4979. https://doi.org/10.3390/ijms26114979

Vancouver

Papadakos SP, Georgiadou C, Argyrou A, Michailidou E, Thanos C, Vogli S, et al. Inflammatory Bowel Disease (IBD)-Associated Colorectal Cancer (CRC): Is cGAS-STING Pathway Targeting the Key to Chemoprevention?. International Journal of Molecular Sciences. 2025;26(11):4979. doi:10.3390/ijms26114979

BibTeX
@article{Papadakos2025,
  author = {Papadakos, Stavros P and Georgiadou, Chara and Argyrou, Alexandra and Michailidou, Elisavet and Thanos, Charalampos and Vogli, Stamatina and Siakavellas, Spyros I and Manolakopoulos, Spillios and Theocharis, Stamatios},
  title = {Inflammatory Bowel Disease (IBD)-Associated Colorectal Cancer (CRC): Is cGAS-STING Pathway Targeting the Key to Chemoprevention?},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  volume = {26},
  number = {11},
  pages = {4979},
  doi = {10.3390/ijms26114979}
}
Kostenlos starten →